Wednesday, July 27, 2011

Citalopram-Sandoz




Citalopram-Sandoz may be available in the countries listed below.


Ingredient matches for Citalopram-Sandoz



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Citalopram-Sandoz in the following countries:


  • Austria

  • Belgium

  • Denmark

  • Estonia

  • France

  • Germany

  • Italy

  • Luxembourg

  • Netherlands

  • Spain

  • Sweden

Citalopram hydrochloride (a derivative of Citalopram) is reported as an ingredient of Citalopram-Sandoz in the following countries:


  • Italy

International Drug Name Search

Eklivan




Eklivan may be available in the countries listed below.


Ingredient matches for Eklivan



Somatostatin

Somatostatin is reported as an ingredient of Eklivan in the following countries:


  • Greece

  • Serbia

International Drug Name Search

Tuesday, July 26, 2011

BetaTan


Generic Name: brompheniramine/carbetapentane/phenylephrine (brome fen IR a meen, kar be ta PEN tane, fen il EF rin)

Brand Names: BetaTan, Pulmari, VazoTan


What is brompheniramine, carbetapentane and phenylephrine?

Carbetapentane is a cough suppressant.


Brompheniramine is an antihistamine. It blocks the effects of the naturally occurring chemical histamine in the body. Histamine can produce allergy symptoms such as sneezing, runny nose, and watery eyes.


Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of brompheniramine, carbetapentane and phenylephrine is used to treat cough and nasal congestion associated with allergies or the common cold.


Brompheniramine, carbetapentane and phenylephrine may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about brompheniramine, carbetapentane and phenylephrine?


Do not use brompheniramine, carbetapentane and phenylephrine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take brompheniramine, carbetapentane and phenylephrine before the MAO inhibitor has cleared from your body. This medication can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of brompheniramine, carbetapentane and phenylephrine. Do not use any other over-the-counter cough, cold, or allergy medications without first asking your doctor or pharmacist. Brompheniramine or phenylephrine are contained in many medicines available over the counter. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains brompheniramine, carbetapentane, or phenylephrine.

Avoid using other medicines that make you sleepy (such as cold medicine, pain medication, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by brompheniramine, carbetapentane, and phenylephrine.


What should I discuss with my healthcare provider before taking brompheniramine, carbetapentane and phenylephrine?


Do not use brompheniramine, carbetapentane and phenylephrine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take brompheniramine, carbetapentane and phenylephrine before the MAO inhibitor has cleared from your body. Do not take this medication if you are allergic to brompheniramine, carbetapentane, or phenylephrine. These medications are contained in many cough, cold, and allergy medications.

Before taking this medication, tell your doctor if you are allergic to any drugs, or if you have:



  • a history of head injury or seizure disorder;




  • sleep apnea (periods of not breathing during sleep);




  • thyroid problems;




  • asthma, emphysema, or chronic obstructive pulmonary disease (COPD);




  • gallbladder disease;




  • Addison's disease;




  • diabetes;




  • glaucoma;




  • an ulcer or an obstruction in the stomach;




  • bladder problems or difficulty urinating;



  • an enlarged prostate;


  • high blood pressure, irregular heartbeats, or any type of heart disease;



  • kidney disease; or

  • liver disease.

If you have any of these conditions, you may not be able to use brompheniramine, carbetapentane, and phenylephrine, or you may need a dosage adjustment or special tests during treatment.


This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Brompheniramine, carbetapentane and phenylephrine can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Older adults may be more likely to have side effects from this medication.

How should I take brompheniramine, carbetapentane and phenylephrine?


Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label.


Shake the oral suspension (liquid) well just before you measure a dose. To be sure you get the correct dose, measure the liquid with a marked measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.

Call your doctor if your symptoms do not improve, if they get worse, or if you develop a fever.


Store this medicine at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Symptoms of a brompheniramine, carbetapentane and phenylephrine overdose may include dry mouth, large pupils, warmth or tingling under the skin, nausea, vomiting, restless feeling, or hallucinations.


What should I avoid while taking brompheniramine, carbetapentane and phenylephrine?


This medication can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of brompheniramine, carbetapentane and phenylephrine. Do not use any other over-the-counter cough, cold, or allergy medications without first asking your doctor or pharmacist. Brompheniramine or phenylephrine are contained in many medicines available over the counter. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains brompheniramine, carbetapentane, or phenylephrine.

Avoid using other medicines that make you sleepy (such as cold medicine, pain medication, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by brompheniramine, carbetapentane, and phenylephrine.


Brompheniramine, carbetapentane and phenylephrine side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Less serious side effects are more likely to occur with this medication, such as:



  • dryness of the eyes, nose, or mouth;




  • drowsiness or dizziness;




  • blurred vision;




  • difficulty urinating; or




  • excitation (in children).



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect brompheniramine, carbetapentane and phenylephrine?


There may be other drugs not listed that can affect brompheniramine, carbetapentane, and phenylephrine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More BetaTan resources


  • BetaTan Side Effects (in more detail)
  • BetaTan Use in Pregnancy & Breastfeeding
  • BetaTan Drug Interactions
  • BetaTan Support Group
  • 0 Reviews for BetaTan - Add your own review/rating


  • BetaTan Consumer Overview

  • BetaTan Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Brompheniramine/Carbetapentane/Phenylephrine Liquid MedFacts Consumer Leaflet (Wolters Kluwer)

  • Trexbrom Prescribing Information (FDA)



Compare BetaTan with other medications


  • Cold Symptoms
  • Cough and Nasal Congestion
  • Hay Fever


Where can I get more information?


  • Your pharmacist has information about brompheniramine, carbetapentane and phenylephrine written for health professionals that you may read.

See also: BetaTan side effects (in more detail)


Reteven




Reteven may be available in the countries listed below.


Ingredient matches for Reteven



Oxybutynin

Oxybutynin is reported as an ingredient of Reteven in the following countries:


  • Venezuela

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Reteven in the following countries:


  • Peru

International Drug Name Search

Thursday, July 21, 2011

Braxan




Braxan may be available in the countries listed below.


Ingredient matches for Braxan



Amiodarone

Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Braxan in the following countries:


  • Mexico

International Drug Name Search

Saturday, July 16, 2011

Retisert


Retisert is a brand name of fluocinolone ophthalmic, approved by the FDA in the following formulation(s):


RETISERT (fluocinolone acetonide - implant; intravitreal)



  • Manufacturer: BAUSCH AND LOMB

    Approval date: April 8, 2005

    Strength(s): 0.59MG [RLD]

Has a generic version of Retisert been approved?


No. There is currently no therapeutically equivalent version of Retisert available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Retisert. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Method for treating and/or preventing retinal diseases with sustained release corticosteroids
    Patent 6,217,895
    Issued: April 17, 2001
    Inventor(s): Guo; Hong & Ashton; Paul
    Assignee(s): Control Delivery Systems
    The present invention relates to a method for administering a corticosteroid to a posterior segment of an eye. In the method, a sustained release device is implanted to deliver the corticosteroid to the eye. The aqueous corticosteroid concentration remains less than vitreous corticosteroid concentration during release of the corticosteroid from the device.
    Patent expiration dates:

    • March 22, 2019
      ✓ 
      Patent use: TREATMENT OF CHRONIC NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT OF THE EYE
      ✓ 
      Drug product




  • Method for treating and/or preventing retinal diseases with sustained release corticosteroids
    Patent 6,548,078
    Issued: April 15, 2003
    Inventor(s): Hong; Guo & Paul; Ashton
    Assignee(s): Control Delivery Systems
    The present invention relates to a method for administering a corticosteroid to a posterior segment of an eye. In the method, a sustained release device is implanted to deliver the corticosteroid to the eye. The aqueous corticosteroid concentration remains less than vitreous corticosteroid concentration during release of the corticosteroid from the device.
    Patent expiration dates:

    • March 22, 2019
      ✓ 
      Patent use: TREATMENT OF CHRONIC NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT OF THE EYE
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • April 8, 2012 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Retisert Consumer Information (Drugs.com)
  • Retisert Implant Consumer Information (Wolters Kluwer)
  • Retisert Consumer Information (Cerner Multum)
  • Retisert eent AHFS DI Monographs (ASHP)
  • Fluocinolone Acetonide Implant Consumer Information (Wolters Kluwer)
  • Fluocinolone ophthalmic implant Consumer Information (Cerner Multum)
  • Fluocinolone Acetonide eent AHFS DI Monographs (ASHP)

Tuesday, July 12, 2011

Kovinal




Kovinal may be available in the countries listed below.


Ingredient matches for Kovinal



Nedocromil

Nedocromil sodium (a derivative of Nedocromil) is reported as an ingredient of Kovinal in the following countries:


  • Italy

International Drug Name Search

Mirtazapina Farmabion




Mirtazapina Farmabion may be available in the countries listed below.


Ingredient matches for Mirtazapina Farmabion



Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapina Farmabion in the following countries:


  • Spain

International Drug Name Search

Monday, July 11, 2011

Flucidal




Flucidal may be available in the countries listed below.


Ingredient matches for Flucidal



Niflumic Acid

Niflumic Acid is reported as an ingredient of Flucidal in the following countries:


  • Algeria

International Drug Name Search

Thursday, July 7, 2011

Carbimazol Henning




Carbimazol Henning may be available in the countries listed below.


Ingredient matches for Carbimazol Henning



Carbimazole

Carbimazole is reported as an ingredient of Carbimazol Henning in the following countries:


  • Germany

International Drug Name Search

Wednesday, July 6, 2011

Ethomid




Ethomid may be available in the countries listed below.


Ingredient matches for Ethomid



Ethionamide

Ethionamide is reported as an ingredient of Ethomid in the following countries:


  • Georgia

International Drug Name Search